Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit

Keyphrases

• Vasospasm 100%
• Intensive Care Unit 100%
• Aneurysmal Subarachnoid Hemorrhage (aSAH) 100%
• Delayed Cerebral Ischemia 100%
• Oral Administration 50%
• Magnesium 50%
• Statins 50%
• Major Contributor 50%
• Patient Management 50%
• Cisternal 50%
• Thrombolysis 50%
• Cerebral Vasospasm 50%
• Microparticles 50%
• Subarachnoid Space 50%
• Calcium Channel Blockers 50%
• Hypotension 50%
• Sustained Release 50%
• Intravenous Administration 50%
• Nimodipine 50%
• Direct Administration 50%
• Large Trials 50%
• Intraventricular Administration 50%
• Intensive Care Unit Management 50%
• Transluminal Angioplasty 50%
• Hypervolemia 50%
• Clazosentan 50%
• Lumbar Cerebrospinal Fluid Drainage 50%
• Cisternal Irrigation 50%
• Tirilazad 50%
• Sustained Release Pellets 50%

Medicine and Dentistry

• Vasospasm 100%
• Brain Ischemia 100%
• Intensive Care Unit 100%
• Subarachnoid Hemorrhage 100%
• Sustained Drug Release 100%
• Blood Clot Lysis 50%
• Statin 50%
• Magnesium 50%
• Calcium Channel Blocking Agent 50%
• Cerebrospinal Fluid Drainage 50%
• Brain Vasospasm 50%
• Percutaneous Transluminal Angioplasty 50%
• Microparticle 50%
• Subarachnoid Space 50%
• Hypotension 50%
• Hypervolemia 50%
• Nimodipine 50%
• Clazosentan 50%
• Tirilazad 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Ischemia 100%
• Vasospasm 100%
• Subarachnoid Hemorrhage 100%
• Sustained Release 100%
• Microparticle 50%
• Calcium Channel Blocker 50%
• Hypotension 50%
• Nimodipine 50%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 50%
• Brain Vasospasm 50%
• Hypervolemia 50%
• Clazosentan 50%
• Tirilazad 50%